Literature DB >> 27592227

Expression of SHANK3 in the Temporal Neocortex of Patients with Intractable Temporal Epilepsy and Epilepsy Rat Models.

Yanke Zhang1, Baobing Gao2, Yan Xiong1, Fangshuo Zheng1, Xin Xu1, Yong Yang1, Yida Hu1, Xuefeng Wang3,4,5.   

Abstract

SH3 and multiple ankyrin (ANK) repeat domain 3 (SHANK3) is a synaptic scaffolding protein enriched in the postsynaptic density of excitatory synapses. SHANK3 plays an important role in the formation and maturation of excitatory synapses. In the brain, SHANK3 directly or indirectly interacts with various synaptic molecules including N-methyl-D-aspartate receptor, the metabotropic glutamate receptor (mGluR), and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor. Previous studies have shown that Autism spectrum disorder is a result of mutations of the main SHANK3 isoforms, which may be due to deficit in excitatory synaptic transmission and plasticity. Recently, accumulating evidence has demonstrated that overexpression of SHANK3 could induce seizures in vivo. However, little is known about the role of SHANK3 in refractory temporal lobe epilepsy (TLE). Therefore, we investigated the expression pattern of SHANK3 in patients with intractable temporal lobe epilepsy and in pilocarpine-induced models of epilepsy. Immunofluorescence, immunohistochemistry, and western blot analysis were used to locate and determine the expression of SHANK3 in the temporal neocortex of patients with epilepsy, and in the hippocampus and temporal lobe cortex of rats in a pilocarpine-induced epilepsy model. Double-labeled immunofluorescence showed that SHANK3 was mainly expressed in neurons. Western blot analysis confirmed that SHANK3 expression was increased in the neocortex of TLE patients and rats. These results indicate that SHANK3 participates in the pathology of epilepsy.

Entities:  

Keywords:  Epilepsy; SH3 and multiple ankyrin repeat domain 3; SHANK3; Temporal lobe epilepsy

Mesh:

Substances:

Year:  2016        PMID: 27592227     DOI: 10.1007/s10571-016-0423-7

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  47 in total

1.  An architectural framework that may lie at the core of the postsynaptic density.

Authors:  Marisa K Baron; Tobias M Boeckers; Bianca Vaida; Salem Faham; Mari Gingery; Michael R Sawaya; Danielle Salyer; Eckart D Gundelfinger; James U Bowie
Journal:  Science       Date:  2006-01-27       Impact factor: 47.728

2.  A patient with the classic features of Phelan-McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72-Mb deletion in the 22q13.2 region.

Authors:  Kristi Simenson; Eve Õiglane-Shlik; Rita Teek; Kati Kuuse; Katrin Õunap
Journal:  Am J Med Genet A       Date:  2013-12-20       Impact factor: 2.802

Review 3.  Molecular signaling mechanisms underlying epileptogenesis.

Authors:  James O McNamara; Yang Zhong Huang; A Soren Leonard
Journal:  Sci STKE       Date:  2006-10-10

Review 4.  Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies.

Authors:  Andreas M Grabrucker; Michael J Schmeisser; Michael Schoen; Tobias M Boeckers
Journal:  Trends Cell Biol       Date:  2011-08-15       Impact factor: 20.808

Review 5.  AMPA receptors as a molecular target in epilepsy therapy.

Authors:  M A Rogawski
Journal:  Acta Neurol Scand Suppl       Date:  2013

Review 6.  The neurobiology of epilepsy.

Authors:  Helen E Scharfman
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

7.  Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders.

Authors:  Stefanie Grabrucker; Linda Jannetti; Matti Eckert; Simone Gaub; Resham Chhabra; Stefanie Pfaender; Katharina Mangus; Parameshwar Pasham Reddy; Vladan Rankovic; Michael J Schmeisser; Michael R Kreutz; Günter Ehret; Tobias M Boeckers; Andreas M Grabrucker
Journal:  Brain       Date:  2013-11-25       Impact factor: 13.501

8.  Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects.

Authors:  Eva M Jimenez-Mateos; Tobias Engel; Paula Merino-Serrais; Ross C McKiernan; Katsuhiro Tanaka; Genshin Mouri; Takanori Sano; Colm O'Tuathaigh; John L Waddington; Suzanne Prenter; Norman Delanty; Michael A Farrell; Donncha F O'Brien; Ronán M Conroy; Raymond L Stallings; Javier DeFelipe; David C Henshall
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

9.  Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication.

Authors:  Ozlem Bozdagi; Takeshi Sakurai; Danae Papapetrou; Xiaobin Wang; Dara L Dickstein; Nagahide Takahashi; Yuji Kajiwara; Mu Yang; Adam M Katz; Maria Luisa Scattoni; Mark J Harris; Roheeni Saxena; Jill L Silverman; Jacqueline N Crawley; Qiang Zhou; Patrick R Hof; Joseph D Buxbaum
Journal:  Mol Autism       Date:  2010-12-17       Impact factor: 7.509

10.  Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome.

Authors:  Maria Clara Bonaglia; Roberto Giorda; Silvana Beri; Cristina De Agostini; Francesca Novara; Marco Fichera; Lucia Grillo; Ornella Galesi; Annalisa Vetro; Roberto Ciccone; Maria Teresa Bonati; Sabrina Giglio; Renzo Guerrini; Sara Osimani; Susan Marelli; Claudio Zucca; Rita Grasso; Renato Borgatti; Elisa Mani; Cristina Motta; Massimo Molteni; Corrado Romano; Donatella Greco; Santina Reitano; Anna Baroncini; Elisabetta Lapi; Antonella Cecconi; Giulia Arrigo; Maria Grazia Patricelli; Chiara Pantaleoni; Stefano D'Arrigo; Daria Riva; Francesca Sciacca; Bernardo Dalla Bernardina; Leonardo Zoccante; Francesca Darra; Cristiano Termine; Emanuela Maserati; Stefania Bigoni; Emanuela Priolo; Armand Bottani; Stefania Gimelli; Frederique Bena; Alfredo Brusco; Eleonora di Gregorio; Irene Bagnasco; Ursula Giussani; Lucio Nitsch; Pierluigi Politi; Maria Luisa Martinez-Frias; Maria Luisa Martínez-Fernández; Nieves Martínez Guardia; Anna Bremer; Britt-Marie Anderlid; Orsetta Zuffardi
Journal:  PLoS Genet       Date:  2011-07-14       Impact factor: 5.917

View more
  5 in total

1.  Interactions between GHRH and GABAARs in the brains of patients with epilepsy and in animal models of epilepsy.

Authors:  Shirong Tang; Zhong Luo; Xiaowei Qiu; Yanke Zhang; Xi Lu; Hao Huang; Zhongxiang Xu; Zucai Xu
Journal:  Sci Rep       Date:  2017-12-22       Impact factor: 4.379

Review 2.  nArgBP2-SAPAP-SHANK, the core postsynaptic triad associated with psychiatric disorders.

Authors:  Sang-Eun Lee; Jung Ah Kim; Sunghoe Chang
Journal:  Exp Mol Med       Date:  2018-04-09       Impact factor: 8.718

3.  Tandospirone, a Partial 5-HT1A Receptor Agonist, Administered Systemically or Into Anterior Cingulate Attenuates Repetitive Behaviors in Shank3B Mice.

Authors:  Jeffrey T Dunn; Jessica Mroczek; Harsh R Patel; Michael E Ragozzino
Journal:  Int J Neuropsychopharmacol       Date:  2020-11-26       Impact factor: 5.176

4.  G-alpha interacting protein interacting protein, C terminus 1 regulates epileptogenesis by increasing the expression of metabotropic glutamate receptor 7.

Authors:  Yong Liu; You Wang; Juan Yang; Tao Xu; Changhong Tan; Peng Zhang; Qiankun Liu; Yangmei Chen
Journal:  CNS Neurosci Ther       Date:  2021-10-22       Impact factor: 5.243

5.  SAPAP3 regulates epileptic seizures involving GluN2A in post-synaptic densities.

Authors:  Yanke Zhang; Junhong Wu; Yin Yan; Yixue Gu; Yuanlin Ma; Min Wang; Hui Zhang; Kaiyan Tao; Yang Lü; Weihua Yu; Wei Jing; Xuefeng Wang; Xin Tian
Journal:  Cell Death Dis       Date:  2022-05-05       Impact factor: 9.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.